Âé¶¹´«Ã½

    Advertisement
    Pharmacy Times10:49PBGENE-HBV FDA Genetics
    Zacks09:58PBGENE-HBV FDA Genetics
    Korea Biomedical Review00:37ToolGen Genetics Biology
    News-Medical.Net07:37DNA Genetics
    Tech Explorist08:50DNA Genetics
    HumanProgress11:50Verve Biology Biotechnology
    Pharmaceutical Technology15:13Verve Biology Biotechnology
    Swimming World Magazine13:45Biology
    Genetic Engineering and Biotechnology News12:08Biology
    Genetic Engineering and Biotechnology News09:43Genetics Biology
    Genetic Engineering and Biotechnology News11:32EditCo Biology Genetics
    Drug Target Review04:08Genetics
    WOWT12:11Genetics
    In the last half-hour
    University of Bristol05:25
    Yesterday
    Nature.com20:08 23-Apr-25
    Zacks19:03 23-Apr-25
    Longevity Technology12:39 23-Apr-25
    ScienceDaily11:51 23-Apr-25
    Nature.com11:07 23-Apr-25
    Business Wire (Press Release)09:06 23-Apr-25
    University of Rochester Medical Center (Press Release)08:23 23-Apr-25
    Business Wire (Press Release)07:34 23-Apr-25
    In the last 7 days
    News-Medical.Net21:26 22-Apr-25
    Genetic Engineering and Biotechnology News21:25 22-Apr-25
    Nature.com11:43 22-Apr-25
    Genetic Engineering and Biotechnology News11:32 22-Apr-25
    Pharmacy Times10:49 22-Apr-25
    Business Wire (Press Release)09:01 22-Apr-25
    TipRanks08:37 22-Apr-25
    News-Medical.Net06:40 22-Apr-25
    Korea Biomedical Review00:37 22-Apr-25
    ENDPOINTS11:07 21-Apr-25
    Zacks10:05 21-Apr-25
    PR Newswire (Press Release)04:03 21-Apr-25
    Nature.com00:32 21-Apr-25
    The Motley Fool09:19 20-Apr-25
    Genetic Engineering and Biotechnology News09:43 18-Apr-25
    The Economist09:38 18-Apr-25
    Drug Target Review04:08 18-Apr-25
    Zacks19:13 17-Apr-25
    BioWorld17:06 17-Apr-25
    Swimming World Magazine13:45 17-Apr-25
    The Times of India13:19 17-Apr-25
    HumanProgress11:50 17-Apr-25
    GlobeNewswire (Press Release)05:16 17-Apr-25
    In the last month
    Simply Wall St16:41 16-Apr-25
    WOWT12:11 16-Apr-25
    Nature.com11:06 16-Apr-25
    Nature.com11:06 16-Apr-25
    Zacks09:58 16-Apr-25
    Fruitnet09:51 16-Apr-25
    CGIAR09:33 16-Apr-25
    Fortune09:09 16-Apr-25
    Labiotech09:04 16-Apr-25
    Tech Explorist08:50 16-Apr-25
    News-Medical.Net07:37 16-Apr-25
    Labiotech02:38 16-Apr-25
    Nature.com19:27 15-Apr-25
    Nature.com07:44 15-Apr-25
    RTT News07:35 15-Apr-25
    Newswise (Press Release)07:32 15-Apr-25
    Business Wire (Press Release)07:01 15-Apr-25
    Chemistry World Magazine04:08 15-Apr-25
    Newswise (Press Release)17:37 14-Apr-25
    Pharmaceutical Technology15:13 14-Apr-25
    ScienceDaily14:37 14-Apr-25
    TCTMD14:11 14-Apr-25
    Boston Globe12:46 14-Apr-25
    Benzinga11:41 14-Apr-25
    BioPharma Dive11:08 14-Apr-25
    Business Wire (Press Release)11:06 14-Apr-25
    NeuroLogica Blog10:38 14-Apr-25
    PRWeb (Press Release)08:34 14-Apr-25
    ENDPOINTS07:01 14-Apr-25
    The Motley Fool14:52 12-Apr-25
    Northwestern Now14:23 11-Apr-25
    EarthSky06:10 11-Apr-25
    The Motley Fool03:48 11-Apr-25
    Nature.com19:54 10-Apr-25
    Zacks18:58 10-Apr-25
    Genetic Engineering and Biotechnology News15:00 10-Apr-25
    Genetic Engineering and Biotechnology News14:55 10-Apr-25
    Genetic Engineering and Biotechnology News12:08 10-Apr-25
    ScienceDaily08:15 10-Apr-25
    BusinessGreen07:28 10-Apr-25
    Business Wire (Press Release)07:02 10-Apr-25
    Nature.com05:18 10-Apr-25
    ScienceDaily15:49 9-Apr-25
    News-Medical.Net15:46 9-Apr-25
    The Independent14:11 9-Apr-25
    Nature.com11:52 9-Apr-25
    Nature.com11:52 9-Apr-25
    Zacks10:03 9-Apr-25
    The Independent06:03 9-Apr-25
    Nature.com04:45 9-Apr-25
    Chemistry World Magazine04:35 9-Apr-25
    Drug Discovery & Development21:53 8-Apr-25
    MailOnline14:59 8-Apr-25
    Nature World News13:52 8-Apr-25
    Drug Discovery & Development13:35 8-Apr-25
    The Conversation (UK)13:20 8-Apr-25
    New Zealand Herald13:08 8-Apr-25
    Drug Discovery & Development13:00 8-Apr-25
    NFU Scotland08:58 8-Apr-25
    PR Newswire (Press Release)08:40 8-Apr-25
    British Medical Journal08:10 8-Apr-25
    Fruitnet05:22 8-Apr-25
    PR Newswire (Press Release)01:02 8-Apr-25
    National World14:59 7-Apr-25
    Kuwait Times12:31 7-Apr-25
    European Pharmaceutical Manufacturer11:34 7-Apr-25
    OncLive09:14 7-Apr-25
    Scottish Daily Express08:39 7-Apr-25
    The Motley Fool08:11 7-Apr-25
    The Motley Fool07:41 7-Apr-25
    Loughborough University05:13 7-Apr-25
    Chemistry World Magazine04:11 7-Apr-25
    Hollywood Reporter15:20 6-Apr-25
    CNET09:19 6-Apr-25
    The National, Scotland02:16 6-Apr-25
    Nature.com01:35 6-Apr-25
    The Washington Post01:11 6-Apr-25
    Macau Business23:38 5-Apr-25
    Malay Mail23:20 5-Apr-25
    Malay Mail23:10 5-Apr-25
    Simply Wall St20:01 5-Apr-25
    ENDPOINTS18:42 5-Apr-25
    Yahoo! UK & Ireland18:38 5-Apr-25
    view more headlines
    24 Apr 05:25

    About our CRISPR/Gene Editing news

    Latest news on CRISPR/Gene Editing, covering breakthroughs, applications, ethics, regulations, and implications for health, agriculture, and biotechnology. Stay informed on this revolutionary technology.

    CRISPR/Cas9, the groundbreaking gene-editing tool, has revolutionised the field of genetics and biotechnology since its discovery in 2012. Developed by scientists Jennifer Doudna and Emmanuelle Charpentier, who were awarded the Nobel Prize in Chemistry in 2020, CRISPR allows for precise, efficient, and cost-effective editing of DNA sequences in living organisms.

    The potential applications of CRISPR are vast, spanning healthcare, agriculture, and beyond. In medicine, CRISPR holds promise for treating genetic disorders, developing novel therapies for diseases like cancer and HIV, and even potentially enhancing human traits. Recent breakthroughs include the first clinical trials of CRISPR-based treatments for sickle cell anemia and beta-thalassemia, as well as advancements in using CRISPR to target antibiotic-resistant bacteria.

    In agriculture, CRISPR is being explored to develop more resilient, nutritious, and sustainable crops, as well as to create disease-resistant livestock. Companies like Corteva Agriscience and Calyxt are at the forefront of these efforts. However, the use of CRISPR in agriculture has also sparked debates about GMO regulations, labelling, and public acceptance.

    Despite its immense potential, CRISPR also raises significant ethical and societal concerns. The prospect of human germline editing, which could alter the genetic makeup of future generations, has been particularly controversial. In 2018, Chinese scientist He Jiankui claimed to have created the world's first gene-edited babies, sparking global outcry and calls for stricter oversight. Organizations like the World Health Organization and the National Academies of Sciences have issued guidelines and recommendations for the responsible development and governance of gene editing.

    Stay up-to-date on the latest CRISPR/Gene Editing news with our dedicated feed, covering everything from cutting-edge research and clinical trials to policy developments and societal debates, as this transformative technology continues to shape our future.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.